Your browser doesn't support javascript.
loading
Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032).
Randall, Leslie M; O'Malley, David M; Monk, Bradley J; Coleman, Robert L; Gaillard, Stephanie; Adams, Sarah; Duska, Linda R; Dalton, Heather; Holloway, Robert W; Huang, Marilyn; Chon, Hye Sook; Cloven, Noelle G; ElNaggar, Adam C; O'Cearbhaill, Roisin E; Waggoner, Steven; Tarkar, Aarti; Striha, Alina; Nelsen, Linda M; Baines, Amanda; Samnotra, Vivek; Konstantinopoulos, Panagiotis A.
Afiliación
  • Randall LM; Virginia Commonwealth University, Massey Cancer Center, Richmond, VA, USA. Electronic address: Leslie.Randall@vcuhealth.org.
  • O'Malley DM; The Ohio State University, James Comprehensive Cancer Center, Columbus, OH, USA.
  • Monk BJ; HonorHealth Research Institute, University of Arizona College of Medicine, Phoenix, AZ, USA.
  • Coleman RL; Sarah Cannon Research Institute (SCRI) (GOG), Nashville, TN, USA.
  • Gaillard S; Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Adams S; The University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA.
  • Duska LR; University of Virginia, Charlottesville, VA, USA.
  • Dalton H; Arizona Center for Cancer Care, Phoenix, AZ, USA.
  • Holloway RW; AdventHealth Cancer Institute, Orlando, FL, USA.
  • Huang M; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Chon HS; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Cloven NG; Texas Oncology - Fort Worth, Fort Worth, TX, USA.
  • ElNaggar AC; West Cancer Center & Research Institute, Memphis, TN, USA.
  • O'Cearbhaill RE; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA.
  • Waggoner S; Cleveland Clinic, OH, USA.
  • Tarkar A; GSK, Collegeville, PA, USA.
  • Striha A; Plus-Project Partnership Ltd, Leeds, UK.
  • Nelsen LM; GSK, Collegeville, PA, USA.
  • Baines A; GSK, Stevenage, UK.
  • Samnotra V; GSK, Waltham, MA, USA.
  • Konstantinopoulos PA; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Gynecol Oncol ; 178: 161-169, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37890345
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antineoplásicos Límite: Female / Humans Idioma: En Revista: Gynecol Oncol Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antineoplásicos Límite: Female / Humans Idioma: En Revista: Gynecol Oncol Año: 2023 Tipo del documento: Article